May 16, 2012

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 3, 2012

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

March 30, 2012

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 16, 2012

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

February 17, 2012

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

February 1, 2012

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

January 27, 2012

The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

December 20, 2011

Specialty pharmacy provider The Apothecary Shops is encouraging medication adherence with a cap for pill containers that cues patients with lights and sounds, the company said.

December 8, 2011

A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

May 23, 2011

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

December 9, 2010

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

November 18, 2010

Pfizer got promising results from a late-stage clinical trial of a cancer treatment, the drug...

October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

September 27, 2010

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

September 22, 2010

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...

September 16, 2010

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

August 26, 2010

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

July 18, 2010

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

July 11, 2010

A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...

June 17, 2010

The Food and Drug Administration has approved a drug as an early treatment for a...

March 11, 2010

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

February 18, 2010

The Food and Drug Administration will shorten its review time of a Novartis drug under...

January 18, 2010

The Food and Drug Administration has extended its review period for a lung cancer drug...